SeeThruEquity Issues Update on Q BioMed Highlighting Exclusive Licensing Agreement and Increasing Price Target to $6.00 Biotech Investing
FenoLogica Biosciences Signs Licensing and Collaboration Agreement With the Pacific Northwest Research Institute Biotech Investing
AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals Biotech Investing
